Literature DB >> 11534936

Effect of L-arginine on the course of experimental colitis.

J Mañé1, F Fernández-Bañares, I Ojanguren, E Castellá, X Bertrán, R Bartolí, M Alvarez, M A Gassull.   

Abstract

BACKGROUND AND AIMS: L-Arg is the substrate for nitric oxide, and also for L-ornithine which, in turn, is the precursor for the synthesis of collagen and polyamines. By these different metabolic pathways, L-Arg is involved in the mechanisms of inflammation, tissue repair and fibrosis. Thus, the aim of this study was to assess the effect of both different amounts of L-Arg supplementation and L-Arg-free diets upon colonic inflammatory damage and fibrosis in experimental colitis.
METHODS: Sprague-Dawley rats with trinitrobenzene sulphonic acid (TNBS)-induced colitis received increasing doses of L-Arg (30, 100, 500 mg/day), or D-Arg (500 mg/day). In a second experiment, two L-Arg-free diets (one supplemented with L-Gly) were compared to a L-Arg diet. Nitrite/nitrate release in the lumen of the colon and colonic damage were evaluated. In the first experiment, tissue collagen levels and colonic mucosal proliferation were also assessed.
RESULTS: In the acute phase of colitis, intracolonic nitrite/nitrate levels were significantly higher in the 100 and 500 mg supplemented L-Arg groups than in D-Arg group. However, only rats treated with 500 mg of L-Arg showed moderately higher inflammatory and fibrosis colonic scores than the D-Arg treated rats. There was no significant influence of L-Arg-free diets on the course of TNBS-induced colitis. However, L-Arg diet accelerated weight gain both pre- and post-TNBS.
CONCLUSIONS: These results suggest that normal amounts of L-Arg in the diet are not harmful, whereas both absence of L-Arg or supplementation with high doses of this amino acid may be deleterious. In the former this might be due to a decrease of nitrogen retention in injured rats, whereas in the latter it may result from both nitric oxide-mediated tissue damage and collagen deposition. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11534936     DOI: 10.1054/clnu.2001.0469

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  6 in total

Review 1.  Immunonutrition in head and neck cancer: have a look before surgery!

Authors:  Chiara Bianchini; Andrea Ciorba; Francesco Stomeo; Stefano Pelucchi; Antonio Pastore
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-11       Impact factor: 2.503

2.  Combined arginine and glutamine decrease release of de novo synthesized leukotrienes and expression of proinflammatory cytokines in activated human intestinal mast cells.

Authors:  Sandra Lechowski; Katharina Feilhauer; Ludger Staib; Moïse Coëffier; Stephan C Bischoff; Axel Lorentz
Journal:  Eur J Nutr       Date:  2012-04-20       Impact factor: 5.614

3.  Inhibitor of PI3Kγ ameliorates TNBS-induced colitis in mice by affecting the functional activity of CD4+CD25+FoxP3+ regulatory T cells.

Authors:  R C Dutra; M Cola; D F P Leite; A F Bento; R F Claudino; A F Z Nascimento; P C Leal; J B Calixto
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

4.  Arginase acts as an alternative pathway of L-arginine metabolism in experimental colon anastomosis.

Authors:  M B Witte; N Vogt; C Stuelten; T Gotoh; M Mori; H D Becker
Journal:  J Gastrointest Surg       Date:  2003 Mar-Apr       Impact factor: 3.452

5.  Astragaloside II promotes intestinal epithelial repair by enhancing L-arginine uptake and activating the mTOR pathway.

Authors:  Shih-Yu Lee; Wei-Cheng Tsai; Jung-Chun Lin; Blerina Ahmetaj-Shala; Su-Feng Huang; Wen-Liang Chang; Tsu-Chung Chang
Journal:  Sci Rep       Date:  2017-09-26       Impact factor: 4.379

6.  Experimental Colitis Is Attenuated by Cardioprotective Diet Supplementation That Reduces Oxidative Stress, Inflammation, and Mucosal Damage.

Authors:  Hilda Vargas Robles; Alí Francisco Citalán Madrid; Alexander García Ponce; Angelica Silva Olivares; Mineko Shibayama; Abigail Betanzos; Leonardo Del Valle Mondragón; Porfirio Nava; Michael Schnoor
Journal:  Oxid Med Cell Longev       Date:  2016-01-06       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.